Published Date: 02 Mar 2023
Researchers from the Barts Cancer Institute and the Francis Crick Institute at Queen Mary University of London have discovered why patients with rare blood cancers suffer from the development of poor red blood cells and...
Read Full NewsSusan Corbridge, PhD, and Alanna Kavannagh, MSN, CCRN, discuss the role of advanced practice providers on the evolving pulmonary and critical care teams during CHEST 2025.
The phase 3 study aims to confirm findings from the HEALEY ALS platform trial in patients with early-stage rapidly progressive ALS, which suggested potential benefits of pridopidine across multiple domains.
Holzem spoke in this interview about several additional highlights from her session at SDPA Fall regarding red flags in dermatology and when to admit from the clinic.
Key Skin Cancer Terms Not Understood by Almost 1/3 of Patients Surveyed
1.
Pulled Myeloma Drug Improves Survival in Trial
2.
A study suggests that screening for liver cancer is beneficial for patients with cirrhosis.
3.
What Kate Middleton Reminds Us About the Role of Privacy in Healing.
4.
Study finds primary-care doctors often overlook prostate cancer risk in Black men
5.
Report reveals lung cancer is the leading cause of cancer deaths in Florida
1.
Unlocking the Potential of Leukemia Treatment: A New Hope for Patients
2.
A Novel Gemcitabine-Releasing Intravesical System for Intermediate-Risk Non-Muscle-Invasive Bladder Cancer
3.
Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options
4.
Synovial Sarcoma of Female Urethra: Case Report and Literature Review
5.
The Truth About Marijuana and Its Effect on Mental Health
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
2.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation